Chemical shift Dixon MR imaging to differentiate benign and malignant bone marrow lesions: A cross-sectional study.

Authors

  • Shuvam Ghosh Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.
  • Santosh Kumar Padhy Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.
  • Sibani Patro Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.
  • Maheswar Chaudhury Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.

DOI:

https://doi.org/10.51168/sjhrafrica.v7i2.2705

Keywords:

Chemical shift, Bone marrow lesions, In phase, Out of phase

Abstract

Background:

Bone lesions encompass a wide spectrum of abnormalities ranging from benign growths, such as osteochondromas and enchondromas, to malignant tumors like osteosarcomas and Ewing’s sarcomas.

 Objective:

To quantify the percentage signal loss in bone marrow lesions resulting from replacement of the fatty marrow component by neoplastic tissue, to differentiate benign from malignant bone lesions.

 Methods:

A total of 100 patients with bone lesions were included in this study. Patients of any age group presenting with bone tumors underwent an MRI scan in MR Omega (3 Tesla). The patients were thoroughly counselled, and no contrast agents were used. The % SI drop was calculated as follows: % SI drop = [(SIIP – SIOOP)/SIIP] × 100 (IP-In phase and OOP- Out of phase).

 Results:

Most patients were male (62%). The mean age of the patients was 45.4 years. The majority of the patients had <20% signal intensity drop (54%).  At a 20% drop in signal intensity, malignant and benign lesions had sensitivities of 80% and 85%; specificities of 85% and 88.9%; PPVs of 73.9% and 88.9%; NPVs of 82% and 73.9%; and accuracies of 82% and 82%. 

 Conclusion:

To describe localized and diffuse marrow abnormalities on standard non-contrast imaging, chemical shift imaging is a helpful supplementary magnetic resonance imaging approach. When it comes to detecting cancerous diseases, it is quite sensitive. In almost 46% of individuals with benign illness, a biopsy might be avoided despite its reduced specificity.

 Recommendation:

Larger-scale studies across a wider range of bone marrow lesions to better quantify the percentage signal loss and assess the broader applicability of this MRI technique in clinical practice.

Author Biographies

  • Shuvam Ghosh, Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.

    MD, Radiodiagnosis, currently working as a Senior Resident in the department of Radiodiagnosis, IMS and SUM Hospital, Bhubaneswar.

  • Santosh Kumar Padhy, Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.

    MD, Radiodiagnosis, currently working as an Associate Professor in the department of Radiodiagnosis, IMS and SUM Hospital, Bhubaneswar.

  • Sibani Patro, Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.

    MD, Radiodiagnosis, currently working as an Associate Professor in the department of Radiodiagnosis, IMS and SUM Hospital, Bhubaneswar.

  • Maheswar Chaudhury, Department of Radiodiagnosis, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan Deemed to be University, Bhubaneswar, India.

    MD, Radiodiagnosis, currently working as an Associate Professor in the department of Radiodiagnosis, IMS and SUM Hospital, Bhubaneswar.

References

Keil L. Bone Tumors: Primary Bone Cancers. FP Essent. 2020;493:22-26

Cammoun D, Hendee WR, Davis KA. Clinical Applications of Magnetic Resonance Imaging-Current Status. Western Journal of Medicine. 1985;143(6):793-803.

Oki N, Ikebe Y, Koike H, Ideguchi R, Niino D, Uetani M. FDG-PET vs. chemical shift MR imaging in differentiating intertrabecular metastasis from hematopoietic bone marrow hyperplasia. Jpn J Radiol. 2021;39(11):1077-1085. https://doi.org/10.1007/s11604-021-01149-x

Jahanvi V, Kelkar A. Chemical shift imaging: An indispensable tool in diagnosing musculoskeletal pathologies. SA J Radiol. 2021;25(1):2061 https://doi.org/10.4102/sajr.v25i1.2061

Pezeshk P, Alian A, Chhabra A. Role of chemical shift and Dixon-based techniques in musculoskeletal MR imaging. Eur J Radiol. 2017;94:93-100. https://doi.org/10.1016/j.ejrad.2017.06.011

Kenneally BE, Gutowski CJ, Reynolds AW, Morrison WB, Abraham JA. Utility of opposed-phase magnetic resonance imaging in differentiating sarcoma from benign bone lesions. J Bone Oncol. 2015;4(4):110-4. https://doi.org/10.1016/j.jbo.2015.10.001

Taheri MS, Mirzaei HR, Shahhamzei S, Moharamzad Y. Comparison of Chemical Shift MR Imaging Findings between Vertebral Benign and Metastatic Lesions. International Journal of Cancer Management 2017 10:7. https://doi.org/10.5812/ijcm.8661

van Vucht N, Santiago R, Pressney I, Saifuddin A. Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions. Br J Radiol. 2021;94(1119):20200710. https://doi.org/10.1259/bjr.20200710

Tadros MY, Louka AL. Discrimination between benign and malignant in vertebral marrow lesions with diffusion weighted MRI and chemical shift. Egyptian Journal of Radiology and Nuclear Medicine. 2016;47(2):557-569. https://doi.org/10.1016/j.ejrnm.2016.02.007

Kohl CA, Chivers FS, Lorans R, Roberts CC, Kransdorf MJ. Accuracy of chemical shift MR imaging in diagnosing indeterminate bone marrow lesions in the pelvis: review of a single institution's experience. Skeletal Radiol. 2014;43(8):1079-84. https://doi.org/10.1007/s00256-014-1886-6

Downloads

Published

2026-06-30

Issue

Section

Section of Radiology and Radiotherapy

How to Cite

Chemical shift Dixon MR imaging to differentiate benign and malignant bone marrow lesions: A cross-sectional study. (2026). Student’s Journal of Health Research Africa, 7(2), 9. https://doi.org/10.51168/sjhrafrica.v7i2.2705

Similar Articles

1-10 of 277

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)